← Leaderboards
John W Winkelman
Brigham And Women'S Hospital
$2,642,080
Attributed
$2,642,080
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $471.3K · FY2007–22$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,642,080 · 4
By mechanism
R01$2,101,412 · 1
R21$462,000 · 1
M01$78,668 · 2
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- David A Wellman$16,573,066
- Charles A Czeisler$60,536,935
- Mark G Baxter$13,760,448
- Bernard L Harlow$12,127,387
- Katherine Elizabeth Burdick$8,386,418
Others in their field
Top investigators on “Sleep”
- Chanza Baytop · Westat, Inc.$271,217,917
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Stanley Carlton Ahalt · Univ Of North Carolina Chapel Hill$78,409,067
- Michael W Weiner · Northern California Institute Res &Educ$71,598,372
- Susan S Redline · Brigham And Women'S Hospital$70,983,879
- Richard Gibbs · Baylor College Of Medicine$68,573,551
Research focus
SleepGrantMaintenanceSleep DisturbancesPrevalenceReportingMedicalRelapseEtiologyDiariesDisturbance In AffectAffinityElectroencephalographyBenzodiazepine ReceptorFollow-UpDiagnosticCharacteristicsCreatineFunctional DisorderCingulate CortexAnteriorCostArousalBrain Region
Grant awards (10)
Treatment of Restless Legs Symptoms with Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD: A Pilot Double-blind, Randomized Clinical Trial$210,000
R21 · FY2022 · DA · contact PI
Treatment of Restless Legs Symptoms with Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD: A Pilot Double-blind, Randomized Clinical Trial$252,000
R21 · FY2021 · DA · contact PI
Cortical GABA in MDD and Primary Insomnia with Magnetic Resonance Spectroscopy$426,060
R01 · FY2016 · MH · contact PI
Cortical GABA in MDD and Primary Insomnia with Magnetic Resonance Spectroscopy$416,964
R01 · FY2015 · MH · contact PI
Cortical GABA in MDD and Primary Insomnia with Magnetic Resonance Spectroscopy$416,917
R01 · FY2014 · MH · contact PI
Cortical GABA in MDD and Primary Insomnia with Magnetic Resonance Spectroscopy$325,520
R01 · FY2013 · MH · contact PI
Cortical GABA in MDD and Primary Insomnia with Magnetic Resonance Spectroscopy$145,755
R01 · FY2013 · MH · contact PI
Cortical GABA in MDD and Primary Insomnia with Magnetic Resonance Spectroscopy$370,196
R01 · FY2012 · MH · contact PI
ESZOPICLONE TO COUNTERACT ADVERSE METABOLIC CONSEQUENCES OF PRIMARY INSOMNIA$10,213
M01 · FY2008 · RR · contact PI
ESZOPICLONE TO COUNTERACT ADVERSE METABOLIC CONSEQUENCES OF PRIMARY INSOMNIA$68,455
M01 · FY2007 · RR · contact PI